Showing results (181-190 of 219) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2021
Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemicsKonstantin Chumakov, Michael S Avidan, Christine S Benn, et al.
Plos One|May 24, 2007
Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cellsJennifer Hartt Meyers, J Shawn Justement, Claire W Hallahan, et al.
Plos Pathogens|July 2, 2019
HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cellsJinhee Hyun, Robert S McMahon, Anna L Lang, et al.
Journal of Mid-Life Health|September 16, 2021
Evaluation of the Efficacy and Safety of Rheum rhaponticum Root Extract (ERr 731) for Menopausal Symptoms in Perimenopausal Indian Women: An Interim AnalysisJignesh Shah, Sonia Chandanani, Jayanthi Reddy, et al.
Blood|September 15, 2010
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapySusan Moir, Clarisa M Buckner, Jason Ho, et al.
AIDS (London, England)|November 10, 2009
Therapeutic response to peg-IFN-alpha-2b and ribavirin in HIV/HCV co-infected African-American and Caucasian patients as a function of HCV viral kinetics and interferon pharmacodynamicsLynn Rozenberg, Bart L Haagmans, Avidan U Neumann, et al.
Frontiers in Public Health|October 24, 2022
One vaccine to counter many diseases? Modeling the economics of oral polio vaccine against child mortality and COVID-19Angela Y Chang, Peter Aaby, Michael S Avidan, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 25, 2009
Pharmacological or genetic inactivation of the serotonin transporter improves reversal learning in miceJonathan L Brigman, Poonam Mathur, Judith Harvey-White, et al.
Annals of Internal Medicine|August 9, 2017
Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical TrialSarah Kattakuzhy, Chloe Gross, Benjamin Emmanuel, et al.
AIDS (London, England)|May 20, 2011
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapyAlison A Murphy, Eva Herrmann, Anu O Osinusi, et al.
Pageof 22